- Birmingham committed to the “90:90:90” principle, whereby 90 percent of people living with HIV will know their HIV status, 90 percent of those who know their status will be engaged with clinical care and on anti-HIV therapy, and 90 percent of those on treatment will achieve full viral suppression
- Paris Declaration confirms 13th city to commit to being a Fast-Track City in the effort to end the spread of HIV/AIDS
- HIV/AIDS research powerhouse, UAB stands behind commitment of city to end the spread of the disease
- View visual assets for this story
Birmingham has become one of 13 cities in the United States dedicated to committing local resources to achieve key Paris Declaration goals in the fight against AIDS by 2020 and ending the spread of AIDS by 2030.
State agencies, local organizations and the University of Alabama at Birmingham are partnering to achieve the following by 2020:
- 90 percent of people living with HIV will know their HIV status
- 90 percent of those who know their status will be engaged in care and on antiretroviral therapy (ART)
- 90 percent of those on ART achieving full viral suppression
“If we can achieve the 90-90-90 plan by 2020, along with zero stigma and discrimination against those living with HIV/AIDS, we will be on our way to ending the spread of HIV/AIDS by 2030,” said Michael Mugavero, M.D., professor in the UAB Division of Infectious Diseases and co-director for the UAB Center for AIDS Research. “The only way to effectively do this is by coming together as a community to commit all of our resources to achieve this goal.”
Currently, almost 40 percent of all individuals infected with HIV in Alabama are still not suppressed, meaning their virus is not under complete control with medication. Partners in the Paris Declaration for Birmingham include the City of Birmingham, Alabama Department of Public Health, Jefferson County Department of Public Health, Birmingham AIDS Outreach, Altheia House and others.
“The research at UAB continues to advance within the HIV/AIDS field,” said Michael Saag, M.D., founder of the UAB 1917 Clinic and director of the UAB CFAR. “Without buy-in from our community, we can do only so much to educate, diagnose and treat those living with HIV/AIDS. This partnership will propel us to ‘bend the curve’ downward, leading to eliminating the spread of a disease that continues to take lives.”
The UAB CFAR is one of the seven inaugural Centers for AIDS Research established in 1988 by the National Institutes of Health. A world leader in HIV/AIDS research and patient care, the UAB CFAR has been among the first to make the newest, most effective treatments available to patients, including the combination therapy that today is the standard of care. Always on the cutting edge, the UAB CFAR recently launched a 90-90-90 scientific working group as a centerpiece of the center’s strategic plan. As a chartered universitywide research center, UAB CFAR stimulates interdisciplinary, translational AIDS research that bridges basic, clinical and behavioral sciences.
The Fast-Track Cities initiative was launched on World AIDS Day 2014 in Paris, France. More than 70 high-burden cities around the world have since signed the Paris Declaration on Fast-Track Cities Ending AIDS and engaged political leaders, affected communities, civil society, city health officials, clinical and service providers, and other stakeholders to accelerate their local AIDS responses.
Mayor William Bell signed the Paris Declaration for Birmingham on Aug. 3, 2017.
Known for its innovative and interdisciplinary approach to education at both the graduate and undergraduate levels, the University of Alabama at Birmingham is an internationally renowned research university and academic medical center and the state of Alabama’s largest employer, with some 23,000 employees and an economic impact exceeding $5 billion annually on the state. The five pillars of UAB’s mission deliver knowledge that will change your world: the education of students, who are exposed to multidisciplinary learning and a new world of diversity; research, the creation of new knowledge; patient care, the outcome of ‘bench-to-bedside’ translational knowledge; service to the community at home and around the globe, from free clinics in local neighborhoods to the transformational experience of the arts; and the economic development of Birmingham and Alabama.